Compare MediTrust Health vs SPCARE
Customers evaluate the quality of MediTrust Health's products using the following success metrics.
Overview
MediTrust Health is 7 yrs old and is based in China.
MediTrust Health is an online healthcare payments and pharmaceutical platform enabling consumers to obtain prescription medicine and pay medical costs online. Its services include health benefits and healthcare services, medical insurance, and pharmaceutical commercialization. The company was founded in 2017 and is based in Xuhui, China.
SPCARE is 10 yrs old and is based in China.
SPCARE, a subsidiary of Medbanks, is a commercial insurance cooperation platform specialized in cancer-related medical services.
Demo Video
Product
Information not available because SPCARE has not claimed their profile.
Work for SPCARE? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for SPCARE?
Claim your profile now.
Benefits
Products
Care2Pay
Care2pay, one of MediTrust's core services, is a leading healthcare benefit platform in China. Through innovative payments, innovative retail and innovative services, Care2pay creates an in-depth value chain from chronic diseases drugs to specialty drugs which involves pharmaceutical companies, pharmacies and commercial insurance companies. It solves long-standing issues such as drug accessibility, affordability and the lack of efficacy guarantee while enabling pharmaceutical companies to precisely reach their targeted customer groups and achieve efficient conversions.
Customers
Known Partners
Why They Buy
News & Analysis
MediTrust Health has been mentioned in our research 3 times.
SPCARE has not been mentioned in our research.
Research Articles
Expert Collections
Digital Health 150
150 items
The winners of the second annual CB Insights Digital Health 150.
Digital Health
10,565 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.